SCHEMBL30799595

SCHEMBL30799595

COC(=O)c1sc2ccncc2c1Br

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.58
HSD17B10 Q99714 5/20 0.58
KDM4E B2RXH2 4/20 0.58
GLA P06280 3/20 0.58
GAA P10253 3/20 0.58
HPGD P15428 3/20 0.58
CASP1 P29466 1/20 0.58
HTT P42858 1/20 0.58
CASP7 P55210 1/20 0.58
NCOA1 Q15788 1/20 0.58
RCE1 Q9Y256 1/20 0.58
NCOA3 Q9Y6Q9 1/20 0.58
MAPK1 P28482 2/20 0.47
LMNA P02545 2/20 0.47
MAPT P10636 2/20 0.46
KMT2A Q03164 2/20 0.46
MEN1 O00255 1/20 0.46
ALOX15 P16050 1/20 0.46
ATM Q13315 1/20 0.46
TSHR P16473 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16238134 0.88 ALDH1A1 (0.70) ALDH1A1HSD17B10KDM4EGLAGAA
SCHEMBL4856080 0.84 ALDH1A1 (0.59) ALDH1A1HSD17B10KDM4EGLAGAA
SCHEMBL31752331 0.82 KDM4E (0.79) ALDH1A1HSD17B10KDM4EGLAGAA
SCHEMBL4859874 0.82 ALDH1A1 (0.58) ALDH1A1HSD17B10KDM4EGLAGAA
SCHEMBL7846644 0.82 KDM4E (0.79) ALDH1A1HSD17B10KDM4EGLAGAA
SCHEMBL31751211 0.80 ALDH1A1 (0.56) ALDH1A1HSD17B10KDM4EGLAGAA
SCHEMBL1805430 0.78 LMNA (0.69) ALDH1A1HSD17B10KDM4EGLAGAA
SCHEMBL1813746 0.75 ALDH1A1 (0.72) ALDH1A1HSD17B10KDM4EGLAGAA
SCHEMBL16096073 0.75 LMNA (0.48) ALDH1A1HSD17B10KDM4EGLAGAA
SCHEMBL4858672 0.75 ALDH1A1 (0.72) ALDH1A1HSD17B10KDM4EGLAGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117683042-A Fused tetracyclic compound, preparation method thereof and application thereof in medicines 江苏恒瑞医药股份有限公司 2024-03-12 CN disclosed